nodes	percent_of_prediction	percent_of_DWPC	metapath
SIMEPREVIR—ALB—hematologic cancer	0.125	0.512	CbGaD
SIMEPREVIR—ABCB1—hematologic cancer	0.119	0.488	CbGaD
SIMEPREVIR—CYP1A2—Anagrelide—hematologic cancer	0.0331	0.0643	CbGbCtD
SIMEPREVIR—ABCB1—Lenalidomide—hematologic cancer	0.0201	0.039	CbGbCtD
SIMEPREVIR—SLCO1B1—Irinotecan—hematologic cancer	0.0197	0.0382	CbGbCtD
SIMEPREVIR—CYP1A2—Carmustine—hematologic cancer	0.0174	0.0338	CbGbCtD
SIMEPREVIR—ALB—Imatinib—hematologic cancer	0.0172	0.0335	CbGbCtD
SIMEPREVIR—CYP1A2—Methoxsalen—hematologic cancer	0.0148	0.0287	CbGbCtD
SIMEPREVIR—CYP1A2—Bortezomib—hematologic cancer	0.0141	0.0273	CbGbCtD
SIMEPREVIR—CYP1A2—Daunorubicin—hematologic cancer	0.0135	0.0261	CbGbCtD
SIMEPREVIR—CYP1A2—Alitretinoin—hematologic cancer	0.0132	0.0256	CbGbCtD
SIMEPREVIR—CYP1A2—Thalidomide—hematologic cancer	0.0123	0.0238	CbGbCtD
SIMEPREVIR—CYP3A4—Bexarotene—hematologic cancer	0.012	0.0233	CbGbCtD
SIMEPREVIR—ABCB1—Daunorubicin—hematologic cancer	0.0118	0.0228	CbGbCtD
SIMEPREVIR—ABCB1—Alitretinoin—hematologic cancer	0.0115	0.0224	CbGbCtD
SIMEPREVIR—ALB—Prednisone—hematologic cancer	0.0114	0.022	CbGbCtD
SIMEPREVIR—CYP3A4—Lomustine—hematologic cancer	0.0112	0.0217	CbGbCtD
SIMEPREVIR—CYP3A4—Busulfan—hematologic cancer	0.0112	0.0217	CbGbCtD
SIMEPREVIR—ALB—Irinotecan—hematologic cancer	0.0108	0.0209	CbGbCtD
SIMEPREVIR—CYP1A2—Dacarbazine—hematologic cancer	0.0105	0.0205	CbGbCtD
SIMEPREVIR—SLCO1B1—Methotrexate—hematologic cancer	0.0104	0.0202	CbGbCtD
SIMEPREVIR—CYP1A2—Imatinib—hematologic cancer	0.0103	0.02	CbGbCtD
SIMEPREVIR—CYP3A4—Thiotepa—hematologic cancer	0.00996	0.0193	CbGbCtD
SIMEPREVIR—ABCB1—Imatinib—hematologic cancer	0.00901	0.0175	CbGbCtD
SIMEPREVIR—CYP1A2—Dasatinib—hematologic cancer	0.00828	0.0161	CbGbCtD
SIMEPREVIR—ABCB1—Nilotinib—hematologic cancer	0.00819	0.0159	CbGbCtD
SIMEPREVIR—ABCB1—Vinorelbine—hematologic cancer	0.00812	0.0158	CbGbCtD
SIMEPREVIR—CYP3A4—Methoxsalen—hematologic cancer	0.00775	0.015	CbGbCtD
SIMEPREVIR—CYP3A4—Bortezomib—hematologic cancer	0.00737	0.0143	CbGbCtD
SIMEPREVIR—ABCB1—Dasatinib—hematologic cancer	0.00724	0.0141	CbGbCtD
SIMEPREVIR—ABCB1—Mitoxantrone—hematologic cancer	0.00715	0.0139	CbGbCtD
SIMEPREVIR—CYP3A4—Daunorubicin—hematologic cancer	0.00705	0.0137	CbGbCtD
SIMEPREVIR—ABCB1—Betamethasone—hematologic cancer	0.00637	0.0124	CbGbCtD
SIMEPREVIR—ABCB1—Gemcitabine—hematologic cancer	0.00632	0.0123	CbGbCtD
SIMEPREVIR—ABCB1—Prednisolone—hematologic cancer	0.00629	0.0122	CbGbCtD
SIMEPREVIR—CYP3A4—Cytarabine—hematologic cancer	0.00622	0.0121	CbGbCtD
SIMEPREVIR—CYP3A4—Teniposide—hematologic cancer	0.00612	0.0119	CbGbCtD
SIMEPREVIR—ABCB1—Prednisone—hematologic cancer	0.00594	0.0115	CbGbCtD
SIMEPREVIR—ALB—Methotrexate—hematologic cancer	0.00569	0.0111	CbGbCtD
SIMEPREVIR—CYP3A4—Ifosfamide—hematologic cancer	0.00565	0.011	CbGbCtD
SIMEPREVIR—ABCB1—Irinotecan—hematologic cancer	0.00563	0.0109	CbGbCtD
SIMEPREVIR—CYP3A4—Imatinib—hematologic cancer	0.0054	0.0105	CbGbCtD
SIMEPREVIR—CYP1A2—Etoposide—hematologic cancer	0.00516	0.01	CbGbCtD
SIMEPREVIR—CYP3A4—Ruxolitinib—hematologic cancer	0.00508	0.00987	CbGbCtD
SIMEPREVIR—ABCB1—Vinblastine—hematologic cancer	0.005	0.00972	CbGbCtD
SIMEPREVIR—ABCB1—Vincristine—hematologic cancer	0.00492	0.00955	CbGbCtD
SIMEPREVIR—CYP3A4—Nilotinib—hematologic cancer	0.00491	0.00953	CbGbCtD
SIMEPREVIR—CYP3A4—Vinorelbine—hematologic cancer	0.00487	0.00945	CbGbCtD
SIMEPREVIR—ABCB1—Cisplatin—hematologic cancer	0.00459	0.00891	CbGbCtD
SIMEPREVIR—ABCB1—Etoposide—hematologic cancer	0.00451	0.00875	CbGbCtD
SIMEPREVIR—CYP3A4—Triamcinolone—hematologic cancer	0.00445	0.00864	CbGbCtD
SIMEPREVIR—CYP3A4—Dasatinib—hematologic cancer	0.00434	0.00842	CbGbCtD
SIMEPREVIR—CYP3A4—Mitoxantrone—hematologic cancer	0.00428	0.00832	CbGbCtD
SIMEPREVIR—CYP3A4—Betamethasone—hematologic cancer	0.00382	0.00741	CbGbCtD
SIMEPREVIR—CYP3A4—Prednisolone—hematologic cancer	0.00377	0.00731	CbGbCtD
SIMEPREVIR—ABCB1—Dexamethasone—hematologic cancer	0.00371	0.0072	CbGbCtD
SIMEPREVIR—CYP3A4—Prednisone—hematologic cancer	0.00356	0.00691	CbGbCtD
SIMEPREVIR—CYP3A4—Irinotecan—hematologic cancer	0.00337	0.00655	CbGbCtD
SIMEPREVIR—ABCB1—Doxorubicin—hematologic cancer	0.00308	0.00597	CbGbCtD
SIMEPREVIR—CYP3A4—Vinblastine—hematologic cancer	0.003	0.00582	CbGbCtD
SIMEPREVIR—ABCB1—Methotrexate—hematologic cancer	0.00298	0.00578	CbGbCtD
SIMEPREVIR—CYP3A4—Vincristine—hematologic cancer	0.00295	0.00572	CbGbCtD
SIMEPREVIR—CYP3A4—Etoposide—hematologic cancer	0.0027	0.00524	CbGbCtD
SIMEPREVIR—CYP3A4—Dexamethasone—hematologic cancer	0.00222	0.00431	CbGbCtD
SIMEPREVIR—CTSS—hematopoietic system—hematologic cancer	0.00216	0.123	CbGeAlD
SIMEPREVIR—CYP3A4—Doxorubicin—hematologic cancer	0.00184	0.00358	CbGbCtD
SIMEPREVIR—CTSS—gonad—hematologic cancer	0.00164	0.0932	CbGeAlD
SIMEPREVIR—CTSS—blood—hematologic cancer	0.00143	0.0812	CbGeAlD
SIMEPREVIR—SLCO1B1—hematopoietic system—hematologic cancer	0.0014	0.0793	CbGeAlD
SIMEPREVIR—CTSS—bone marrow—hematologic cancer	0.00139	0.0786	CbGeAlD
SIMEPREVIR—CTSS—lung—hematologic cancer	0.00126	0.0712	CbGeAlD
SIMEPREVIR—CTSS—testis—hematologic cancer	0.00118	0.0672	CbGeAlD
SIMEPREVIR—SLCO1B1—blood—hematologic cancer	0.000927	0.0526	CbGeAlD
SIMEPREVIR—CTSS—lymph node—hematologic cancer	0.000859	0.0487	CbGeAlD
SIMEPREVIR—CYP1A2—hematopoietic system—hematologic cancer	0.000744	0.0422	CbGeAlD
SIMEPREVIR—ALB—testis—hematologic cancer	0.00062	0.0352	CbGeAlD
SIMEPREVIR—CYP3A4—hematopoietic system—hematologic cancer	0.000539	0.0306	CbGeAlD
SIMEPREVIR—CYP1A2—blood—hematologic cancer	0.000493	0.028	CbGeAlD
SIMEPREVIR—ALB—lymph node—hematologic cancer	0.00045	0.0255	CbGeAlD
SIMEPREVIR—CYP1A2—lung—hematologic cancer	0.000432	0.0245	CbGeAlD
SIMEPREVIR—ABCB1—hematopoietic system—hematologic cancer	0.000381	0.0216	CbGeAlD
SIMEPREVIR—CYP3A4—blood—hematologic cancer	0.000357	0.0202	CbGeAlD
SIMEPREVIR—ABCB1—gonad—hematologic cancer	0.00029	0.0164	CbGeAlD
SIMEPREVIR—ABCB1—blood—hematologic cancer	0.000253	0.0143	CbGeAlD
SIMEPREVIR—ABCB1—bone marrow—hematologic cancer	0.000244	0.0139	CbGeAlD
SIMEPREVIR—ABCB1—lung—hematologic cancer	0.000221	0.0126	CbGeAlD
SIMEPREVIR—ABCB1—testis—hematologic cancer	0.000209	0.0119	CbGeAlD
SIMEPREVIR—ABCB1—lymph node—hematologic cancer	0.000151	0.00859	CbGeAlD
SIMEPREVIR—Anaemia—Etoposide—hematologic cancer	0.000137	0.000935	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—hematologic cancer	0.000137	0.000934	CcSEcCtD
SIMEPREVIR—Dyspnoea—Ifosfamide—hematologic cancer	0.000137	0.000932	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Vincristine—hematologic cancer	0.000136	0.000929	CcSEcCtD
SIMEPREVIR—Insomnia—Vincristine—hematologic cancer	0.000135	0.000922	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Carmustine—hematologic cancer	0.000135	0.000922	CcSEcCtD
SIMEPREVIR—Nausea—Nilotinib—hematologic cancer	0.000135	0.000918	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Alitretinoin—hematologic cancer	0.000134	0.000913	CcSEcCtD
SIMEPREVIR—Constipation—Carmustine—hematologic cancer	0.000134	0.000913	CcSEcCtD
SIMEPREVIR—Nausea—Imatinib—hematologic cancer	0.000134	0.000913	CcSEcCtD
SIMEPREVIR—Fatigue—Alitretinoin—hematologic cancer	0.000134	0.000912	CcSEcCtD
SIMEPREVIR—Headache—Vinblastine—hematologic cancer	0.000133	0.000908	CcSEcCtD
SIMEPREVIR—Constipation—Alitretinoin—hematologic cancer	0.000133	0.000905	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Mitoxantrone—hematologic cancer	0.000133	0.000905	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Ifosfamide—hematologic cancer	0.000132	0.000903	CcSEcCtD
SIMEPREVIR—Fatigue—Ifosfamide—hematologic cancer	0.000132	0.000902	CcSEcCtD
SIMEPREVIR—Insomnia—Irinotecan—hematologic cancer	0.000132	0.000898	CcSEcCtD
SIMEPREVIR—Nausea—Cladribine—hematologic cancer	0.000132	0.000897	CcSEcCtD
SIMEPREVIR—Infection—Cisplatin—hematologic cancer	0.000131	0.000896	CcSEcCtD
SIMEPREVIR—Constipation—Ifosfamide—hematologic cancer	0.000131	0.000894	CcSEcCtD
SIMEPREVIR—Dyspnoea—Mitoxantrone—hematologic cancer	0.00013	0.000885	CcSEcCtD
SIMEPREVIR—Dyspnoea—Irinotecan—hematologic cancer	0.00013	0.000885	CcSEcCtD
SIMEPREVIR—Asthenia—Bortezomib—hematologic cancer	0.00013	0.000885	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Gemcitabine—hematologic cancer	0.000129	0.000881	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Vincristine—hematologic cancer	0.000129	0.00088	CcSEcCtD
SIMEPREVIR—Fatigue—Vincristine—hematologic cancer	0.000129	0.000879	CcSEcCtD
SIMEPREVIR—Asthenia—Bleomycin—hematologic cancer	0.000129	0.000878	CcSEcCtD
SIMEPREVIR—Skin disorder—Cisplatin—hematologic cancer	0.000128	0.000876	CcSEcCtD
SIMEPREVIR—Insomnia—Gemcitabine—hematologic cancer	0.000128	0.000875	CcSEcCtD
SIMEPREVIR—Pruritus—Bortezomib—hematologic cancer	0.000128	0.000872	CcSEcCtD
SIMEPREVIR—Constipation—Vincristine—hematologic cancer	0.000128	0.000872	CcSEcCtD
SIMEPREVIR—Rash—Melphalan—hematologic cancer	0.000127	0.000869	CcSEcCtD
SIMEPREVIR—Dermatitis—Melphalan—hematologic cancer	0.000127	0.000868	CcSEcCtD
SIMEPREVIR—Pruritus—Bleomycin—hematologic cancer	0.000127	0.000866	CcSEcCtD
SIMEPREVIR—Asthenia—Vinorelbine—hematologic cancer	0.000127	0.000864	CcSEcCtD
SIMEPREVIR—Dyspnoea—Gemcitabine—hematologic cancer	0.000126	0.000862	CcSEcCtD
SIMEPREVIR—Nausea—Vinblastine—hematologic cancer	0.000126	0.00086	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Irinotecan—hematologic cancer	0.000126	0.000857	CcSEcCtD
SIMEPREVIR—Fatigue—Irinotecan—hematologic cancer	0.000126	0.000856	CcSEcCtD
SIMEPREVIR—Fatigue—Mitoxantrone—hematologic cancer	0.000126	0.000856	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Etoposide—hematologic cancer	0.000125	0.000856	CcSEcCtD
SIMEPREVIR—Pruritus—Vinorelbine—hematologic cancer	0.000125	0.000852	CcSEcCtD
SIMEPREVIR—Constipation—Mitoxantrone—hematologic cancer	0.000124	0.000849	CcSEcCtD
SIMEPREVIR—Constipation—Irinotecan—hematologic cancer	0.000124	0.000849	CcSEcCtD
SIMEPREVIR—Rash—Lenalidomide—hematologic cancer	0.000124	0.000845	CcSEcCtD
SIMEPREVIR—Dermatitis—Lenalidomide—hematologic cancer	0.000124	0.000844	CcSEcCtD
SIMEPREVIR—Headache—Lenalidomide—hematologic cancer	0.000123	0.000839	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Gemcitabine—hematologic cancer	0.000122	0.000835	CcSEcCtD
SIMEPREVIR—Fatigue—Gemcitabine—hematologic cancer	0.000122	0.000834	CcSEcCtD
SIMEPREVIR—Rash—Hydroxyurea—hematologic cancer	0.000122	0.000833	CcSEcCtD
SIMEPREVIR—Dermatitis—Hydroxyurea—hematologic cancer	0.000122	0.000832	CcSEcCtD
SIMEPREVIR—Headache—Hydroxyurea—hematologic cancer	0.000121	0.000828	CcSEcCtD
SIMEPREVIR—Constipation—Gemcitabine—hematologic cancer	0.000121	0.000827	CcSEcCtD
SIMEPREVIR—Asthenia—Thiotepa—hematologic cancer	0.000121	0.000825	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Cisplatin—hematologic cancer	0.00012	0.000821	CcSEcCtD
SIMEPREVIR—Infection—Etoposide—hematologic cancer	0.00012	0.00082	CcSEcCtD
SIMEPREVIR—Nausea—Melphalan—hematologic cancer	0.00012	0.000818	CcSEcCtD
SIMEPREVIR—Pruritus—Thiotepa—hematologic cancer	0.000119	0.000813	CcSEcCtD
SIMEPREVIR—Dyspnoea—Cisplatin—hematologic cancer	0.000118	0.000804	CcSEcCtD
SIMEPREVIR—Skin disorder—Etoposide—hematologic cancer	0.000118	0.000802	CcSEcCtD
SIMEPREVIR—Asthenia—Thalidomide—hematologic cancer	0.000117	0.000798	CcSEcCtD
SIMEPREVIR—Nausea—Lenalidomide—hematologic cancer	0.000117	0.000796	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Methotrexate—hematologic cancer	0.000116	0.000794	CcSEcCtD
SIMEPREVIR—Pruritus—Thalidomide—hematologic cancer	0.000115	0.000787	CcSEcCtD
SIMEPREVIR—Nausea—Hydroxyurea—hematologic cancer	0.000115	0.000785	CcSEcCtD
SIMEPREVIR—Myalgia—Triamcinolone—hematologic cancer	0.000115	0.000781	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Cisplatin—hematologic cancer	0.000114	0.000778	CcSEcCtD
SIMEPREVIR—Rash—Bortezomib—hematologic cancer	0.000114	0.000777	CcSEcCtD
SIMEPREVIR—Dermatitis—Bortezomib—hematologic cancer	0.000114	0.000777	CcSEcCtD
SIMEPREVIR—Headache—Bortezomib—hematologic cancer	0.000113	0.000772	CcSEcCtD
SIMEPREVIR—Rash—Bleomycin—hematologic cancer	0.000113	0.000771	CcSEcCtD
SIMEPREVIR—Dermatitis—Bleomycin—hematologic cancer	0.000113	0.000771	CcSEcCtD
SIMEPREVIR—Asthenia—Carmustine—hematologic cancer	0.000112	0.000766	CcSEcCtD
SIMEPREVIR—Asthenia—Alitretinoin—hematologic cancer	0.000111	0.000759	CcSEcCtD
SIMEPREVIR—Rash—Vinorelbine—hematologic cancer	0.000111	0.000759	CcSEcCtD
SIMEPREVIR—Dermatitis—Vinorelbine—hematologic cancer	0.000111	0.000758	CcSEcCtD
SIMEPREVIR—Headache—Vinorelbine—hematologic cancer	0.000111	0.000754	CcSEcCtD
SIMEPREVIR—Asthenia—Ifosfamide—hematologic cancer	0.00011	0.00075	CcSEcCtD
SIMEPREVIR—Pruritus—Alitretinoin—hematologic cancer	0.00011	0.000749	CcSEcCtD
SIMEPREVIR—Infection—Triamcinolone—hematologic cancer	0.000109	0.000744	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Epirubicin—hematologic cancer	0.000109	0.000743	CcSEcCtD
SIMEPREVIR—Pruritus—Ifosfamide—hematologic cancer	0.000108	0.00074	CcSEcCtD
SIMEPREVIR—Insomnia—Prednisolone—hematologic cancer	0.000108	0.000737	CcSEcCtD
SIMEPREVIR—Dyspnoea—Etoposide—hematologic cancer	0.000108	0.000736	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Methotrexate—hematologic cancer	0.000108	0.000734	CcSEcCtD
SIMEPREVIR—Nausea—Bortezomib—hematologic cancer	0.000107	0.000732	CcSEcCtD
SIMEPREVIR—Asthenia—Vincristine—hematologic cancer	0.000107	0.000731	CcSEcCtD
SIMEPREVIR—Nausea—Bleomycin—hematologic cancer	0.000107	0.000727	CcSEcCtD
SIMEPREVIR—Rash—Thiotepa—hematologic cancer	0.000106	0.000725	CcSEcCtD
SIMEPREVIR—Dermatitis—Thiotepa—hematologic cancer	0.000106	0.000724	CcSEcCtD
SIMEPREVIR—Headache—Thiotepa—hematologic cancer	0.000106	0.00072	CcSEcCtD
SIMEPREVIR—Nausea—Vinorelbine—hematologic cancer	0.000105	0.000715	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Etoposide—hematologic cancer	0.000105	0.000713	CcSEcCtD
SIMEPREVIR—Asthenia—Mitoxantrone—hematologic cancer	0.000104	0.000712	CcSEcCtD
SIMEPREVIR—Asthenia—Irinotecan—hematologic cancer	0.000104	0.000712	CcSEcCtD
SIMEPREVIR—Fatigue—Etoposide—hematologic cancer	0.000104	0.000712	CcSEcCtD
SIMEPREVIR—Myalgia—Dexamethasone—hematologic cancer	0.000104	0.000709	CcSEcCtD
SIMEPREVIR—Myalgia—Betamethasone—hematologic cancer	0.000104	0.000709	CcSEcCtD
SIMEPREVIR—Constipation—Etoposide—hematologic cancer	0.000104	0.000706	CcSEcCtD
SIMEPREVIR—Rash—Thalidomide—hematologic cancer	0.000103	0.000701	CcSEcCtD
SIMEPREVIR—Dermatitis—Thalidomide—hematologic cancer	0.000103	0.0007	CcSEcCtD
SIMEPREVIR—Headache—Thalidomide—hematologic cancer	0.000102	0.000697	CcSEcCtD
SIMEPREVIR—Asthenia—Gemcitabine—hematologic cancer	0.000102	0.000694	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Doxorubicin—hematologic cancer	0.000101	0.000688	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Epirubicin—hematologic cancer	0.000101	0.000686	CcSEcCtD
SIMEPREVIR—Pruritus—Gemcitabine—hematologic cancer	0.0001	0.000684	CcSEcCtD
SIMEPREVIR—Nausea—Thiotepa—hematologic cancer	0.0001	0.000683	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	0.0001	0.000682	CcSEcCtD
SIMEPREVIR—Insomnia—Triamcinolone—hematologic cancer	9.93e-05	0.000678	CcSEcCtD
SIMEPREVIR—Infection—Betamethasone—hematologic cancer	9.9e-05	0.000675	CcSEcCtD
SIMEPREVIR—Infection—Dexamethasone—hematologic cancer	9.9e-05	0.000675	CcSEcCtD
SIMEPREVIR—Rash—Carmustine—hematologic cancer	9.87e-05	0.000673	CcSEcCtD
SIMEPREVIR—Dermatitis—Carmustine—hematologic cancer	9.86e-05	0.000673	CcSEcCtD
SIMEPREVIR—Anaemia—Prednisone—hematologic cancer	9.83e-05	0.00067	CcSEcCtD
SIMEPREVIR—Headache—Carmustine—hematologic cancer	9.81e-05	0.000669	CcSEcCtD
SIMEPREVIR—Dyspnoea—Triamcinolone—hematologic cancer	9.79e-05	0.000668	CcSEcCtD
SIMEPREVIR—Rash—Alitretinoin—hematologic cancer	9.78e-05	0.000667	CcSEcCtD
SIMEPREVIR—Dermatitis—Alitretinoin—hematologic cancer	9.77e-05	0.000666	CcSEcCtD
SIMEPREVIR—Headache—Alitretinoin—hematologic cancer	9.72e-05	0.000663	CcSEcCtD
SIMEPREVIR—Nausea—Thalidomide—hematologic cancer	9.68e-05	0.000661	CcSEcCtD
SIMEPREVIR—Rash—Ifosfamide—hematologic cancer	9.67e-05	0.000659	CcSEcCtD
SIMEPREVIR—Dermatitis—Ifosfamide—hematologic cancer	9.66e-05	0.000659	CcSEcCtD
SIMEPREVIR—Asthenia—Cisplatin—hematologic cancer	9.48e-05	0.000647	CcSEcCtD
SIMEPREVIR—Fatigue—Triamcinolone—hematologic cancer	9.47e-05	0.000646	CcSEcCtD
SIMEPREVIR—Rash—Vincristine—hematologic cancer	9.42e-05	0.000643	CcSEcCtD
SIMEPREVIR—Dermatitis—Vincristine—hematologic cancer	9.42e-05	0.000642	CcSEcCtD
SIMEPREVIR—Headache—Vincristine—hematologic cancer	9.36e-05	0.000639	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Doxorubicin—hematologic cancer	9.31e-05	0.000635	CcSEcCtD
SIMEPREVIR—Nausea—Carmustine—hematologic cancer	9.3e-05	0.000634	CcSEcCtD
SIMEPREVIR—Nausea—Alitretinoin—hematologic cancer	9.21e-05	0.000628	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Methotrexate—hematologic cancer	9.2e-05	0.000628	CcSEcCtD
SIMEPREVIR—Rash—Mitoxantrone—hematologic cancer	9.18e-05	0.000626	CcSEcCtD
SIMEPREVIR—Rash—Irinotecan—hematologic cancer	9.18e-05	0.000626	CcSEcCtD
SIMEPREVIR—Dermatitis—Mitoxantrone—hematologic cancer	9.17e-05	0.000625	CcSEcCtD
SIMEPREVIR—Dermatitis—Irinotecan—hematologic cancer	9.17e-05	0.000625	CcSEcCtD
SIMEPREVIR—Headache—Mitoxantrone—hematologic cancer	9.12e-05	0.000622	CcSEcCtD
SIMEPREVIR—Headache—Irinotecan—hematologic cancer	9.12e-05	0.000622	CcSEcCtD
SIMEPREVIR—Nausea—Ifosfamide—hematologic cancer	9.11e-05	0.000621	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	9.08e-05	0.000619	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Betamethasone—hematologic cancer	9.08e-05	0.000619	CcSEcCtD
SIMEPREVIR—Myalgia—Prednisone—hematologic cancer	9.05e-05	0.000617	CcSEcCtD
SIMEPREVIR—Insomnia—Dexamethasone—hematologic cancer	9.01e-05	0.000615	CcSEcCtD
SIMEPREVIR—Insomnia—Betamethasone—hematologic cancer	9.01e-05	0.000615	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	8.99e-05	0.000613	CcSEcCtD
SIMEPREVIR—Rash—Gemcitabine—hematologic cancer	8.94e-05	0.00061	CcSEcCtD
SIMEPREVIR—Dermatitis—Gemcitabine—hematologic cancer	8.93e-05	0.000609	CcSEcCtD
SIMEPREVIR—Headache—Gemcitabine—hematologic cancer	8.88e-05	0.000606	CcSEcCtD
SIMEPREVIR—Nausea—Vincristine—hematologic cancer	8.88e-05	0.000606	CcSEcCtD
SIMEPREVIR—Asthenia—Etoposide—hematologic cancer	8.69e-05	0.000593	CcSEcCtD
SIMEPREVIR—Nausea—Mitoxantrone—hematologic cancer	8.65e-05	0.00059	CcSEcCtD
SIMEPREVIR—Nausea—Irinotecan—hematologic cancer	8.65e-05	0.00059	CcSEcCtD
SIMEPREVIR—Infection—Prednisone—hematologic cancer	8.62e-05	0.000588	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Epirubicin—hematologic cancer	8.61e-05	0.000587	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Dexamethasone—hematologic cancer	8.6e-05	0.000587	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Betamethasone—hematologic cancer	8.6e-05	0.000587	CcSEcCtD
SIMEPREVIR—Fatigue—Betamethasone—hematologic cancer	8.59e-05	0.000586	CcSEcCtD
SIMEPREVIR—Fatigue—Dexamethasone—hematologic cancer	8.59e-05	0.000586	CcSEcCtD
SIMEPREVIR—Pruritus—Etoposide—hematologic cancer	8.57e-05	0.000584	CcSEcCtD
SIMEPREVIR—Skin disorder—Prednisone—hematologic cancer	8.43e-05	0.000575	CcSEcCtD
SIMEPREVIR—Nausea—Gemcitabine—hematologic cancer	8.42e-05	0.000574	CcSEcCtD
SIMEPREVIR—Rash—Cisplatin—hematologic cancer	8.33e-05	0.000568	CcSEcCtD
SIMEPREVIR—Dermatitis—Cisplatin—hematologic cancer	8.33e-05	0.000568	CcSEcCtD
SIMEPREVIR—Anaemia—Methotrexate—hematologic cancer	8.21e-05	0.00056	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Doxorubicin—hematologic cancer	7.97e-05	0.000543	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Prednisone—hematologic cancer	7.91e-05	0.000539	CcSEcCtD
SIMEPREVIR—Asthenia—Triamcinolone—hematologic cancer	7.88e-05	0.000537	CcSEcCtD
SIMEPREVIR—Nausea—Cisplatin—hematologic cancer	7.85e-05	0.000535	CcSEcCtD
SIMEPREVIR—Insomnia—Prednisone—hematologic cancer	7.85e-05	0.000535	CcSEcCtD
SIMEPREVIR—Pruritus—Triamcinolone—hematologic cancer	7.77e-05	0.00053	CcSEcCtD
SIMEPREVIR—Anaemia—Epirubicin—hematologic cancer	7.69e-05	0.000524	CcSEcCtD
SIMEPREVIR—Rash—Etoposide—hematologic cancer	7.63e-05	0.000521	CcSEcCtD
SIMEPREVIR—Dermatitis—Etoposide—hematologic cancer	7.63e-05	0.00052	CcSEcCtD
SIMEPREVIR—Headache—Etoposide—hematologic cancer	7.59e-05	0.000517	CcSEcCtD
SIMEPREVIR—Myalgia—Methotrexate—hematologic cancer	7.57e-05	0.000516	CcSEcCtD
SIMEPREVIR—Rash—Prednisolone—hematologic cancer	7.53e-05	0.000514	CcSEcCtD
SIMEPREVIR—Dermatitis—Prednisolone—hematologic cancer	7.52e-05	0.000513	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	7.51e-05	0.000512	CcSEcCtD
SIMEPREVIR—Fatigue—Prednisone—hematologic cancer	7.48e-05	0.00051	CcSEcCtD
SIMEPREVIR—Headache—Prednisolone—hematologic cancer	7.48e-05	0.00051	CcSEcCtD
SIMEPREVIR—Constipation—Prednisone—hematologic cancer	7.42e-05	0.000506	CcSEcCtD
SIMEPREVIR—Infection—Methotrexate—hematologic cancer	7.21e-05	0.000491	CcSEcCtD
SIMEPREVIR—Nausea—Etoposide—hematologic cancer	7.19e-05	0.000491	CcSEcCtD
SIMEPREVIR—Asthenia—Betamethasone—hematologic cancer	7.15e-05	0.000488	CcSEcCtD
SIMEPREVIR—Asthenia—Dexamethasone—hematologic cancer	7.15e-05	0.000488	CcSEcCtD
SIMEPREVIR—Anaemia—Doxorubicin—hematologic cancer	7.11e-05	0.000485	CcSEcCtD
SIMEPREVIR—Nausea—Prednisolone—hematologic cancer	7.09e-05	0.000484	CcSEcCtD
SIMEPREVIR—Myalgia—Epirubicin—hematologic cancer	7.08e-05	0.000483	CcSEcCtD
SIMEPREVIR—Pruritus—Dexamethasone—hematologic cancer	7.05e-05	0.000481	CcSEcCtD
SIMEPREVIR—Pruritus—Betamethasone—hematologic cancer	7.05e-05	0.000481	CcSEcCtD
SIMEPREVIR—Skin disorder—Methotrexate—hematologic cancer	7.05e-05	0.00048	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	7.03e-05	0.00048	CcSEcCtD
SIMEPREVIR—Rash—Triamcinolone—hematologic cancer	6.92e-05	0.000472	CcSEcCtD
SIMEPREVIR—Dermatitis—Triamcinolone—hematologic cancer	6.92e-05	0.000472	CcSEcCtD
SIMEPREVIR—Headache—Triamcinolone—hematologic cancer	6.88e-05	0.000469	CcSEcCtD
SIMEPREVIR—Infection—Epirubicin—hematologic cancer	6.74e-05	0.00046	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Methotrexate—hematologic cancer	6.61e-05	0.000451	CcSEcCtD
SIMEPREVIR—Skin disorder—Epirubicin—hematologic cancer	6.59e-05	0.00045	CcSEcCtD
SIMEPREVIR—Insomnia—Methotrexate—hematologic cancer	6.56e-05	0.000447	CcSEcCtD
SIMEPREVIR—Myalgia—Doxorubicin—hematologic cancer	6.55e-05	0.000447	CcSEcCtD
SIMEPREVIR—Nausea—Triamcinolone—hematologic cancer	6.52e-05	0.000445	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	6.51e-05	0.000444	CcSEcCtD
SIMEPREVIR—Dyspnoea—Methotrexate—hematologic cancer	6.47e-05	0.000441	CcSEcCtD
SIMEPREVIR—Rash—Betamethasone—hematologic cancer	6.28e-05	0.000429	CcSEcCtD
SIMEPREVIR—Rash—Dexamethasone—hematologic cancer	6.28e-05	0.000429	CcSEcCtD
SIMEPREVIR—Dermatitis—Betamethasone—hematologic cancer	6.28e-05	0.000428	CcSEcCtD
SIMEPREVIR—Dermatitis—Dexamethasone—hematologic cancer	6.28e-05	0.000428	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Methotrexate—hematologic cancer	6.26e-05	0.000427	CcSEcCtD
SIMEPREVIR—Fatigue—Methotrexate—hematologic cancer	6.25e-05	0.000426	CcSEcCtD
SIMEPREVIR—Headache—Betamethasone—hematologic cancer	6.24e-05	0.000426	CcSEcCtD
SIMEPREVIR—Headache—Dexamethasone—hematologic cancer	6.24e-05	0.000426	CcSEcCtD
SIMEPREVIR—Infection—Doxorubicin—hematologic cancer	6.24e-05	0.000426	CcSEcCtD
SIMEPREVIR—Asthenia—Prednisone—hematologic cancer	6.23e-05	0.000425	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Epirubicin—hematologic cancer	6.18e-05	0.000422	CcSEcCtD
SIMEPREVIR—Pruritus—Prednisone—hematologic cancer	6.14e-05	0.000419	CcSEcCtD
SIMEPREVIR—Insomnia—Epirubicin—hematologic cancer	6.14e-05	0.000419	CcSEcCtD
SIMEPREVIR—Skin disorder—Doxorubicin—hematologic cancer	6.1e-05	0.000416	CcSEcCtD
SIMEPREVIR—Dyspnoea—Epirubicin—hematologic cancer	6.05e-05	0.000413	CcSEcCtD
SIMEPREVIR—Nausea—Betamethasone—hematologic cancer	5.92e-05	0.000404	CcSEcCtD
SIMEPREVIR—Nausea—Dexamethasone—hematologic cancer	5.92e-05	0.000404	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Epirubicin—hematologic cancer	5.86e-05	0.0004	CcSEcCtD
SIMEPREVIR—Fatigue—Epirubicin—hematologic cancer	5.85e-05	0.000399	CcSEcCtD
SIMEPREVIR—Constipation—Epirubicin—hematologic cancer	5.8e-05	0.000396	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	5.72e-05	0.00039	CcSEcCtD
SIMEPREVIR—Insomnia—Doxorubicin—hematologic cancer	5.68e-05	0.000387	CcSEcCtD
SIMEPREVIR—Dyspnoea—Doxorubicin—hematologic cancer	5.6e-05	0.000382	CcSEcCtD
SIMEPREVIR—Rash—Prednisone—hematologic cancer	5.47e-05	0.000373	CcSEcCtD
SIMEPREVIR—Dermatitis—Prednisone—hematologic cancer	5.47e-05	0.000373	CcSEcCtD
SIMEPREVIR—Headache—Prednisone—hematologic cancer	5.44e-05	0.000371	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Doxorubicin—hematologic cancer	5.42e-05	0.00037	CcSEcCtD
SIMEPREVIR—Fatigue—Doxorubicin—hematologic cancer	5.41e-05	0.000369	CcSEcCtD
SIMEPREVIR—Constipation—Doxorubicin—hematologic cancer	5.37e-05	0.000366	CcSEcCtD
SIMEPREVIR—Asthenia—Methotrexate—hematologic cancer	5.2e-05	0.000355	CcSEcCtD
SIMEPREVIR—Nausea—Prednisone—hematologic cancer	5.15e-05	0.000352	CcSEcCtD
SIMEPREVIR—Pruritus—Methotrexate—hematologic cancer	5.13e-05	0.00035	CcSEcCtD
SIMEPREVIR—Asthenia—Epirubicin—hematologic cancer	4.87e-05	0.000332	CcSEcCtD
SIMEPREVIR—Pruritus—Epirubicin—hematologic cancer	4.8e-05	0.000328	CcSEcCtD
SIMEPREVIR—Rash—Methotrexate—hematologic cancer	4.57e-05	0.000312	CcSEcCtD
SIMEPREVIR—Dermatitis—Methotrexate—hematologic cancer	4.57e-05	0.000312	CcSEcCtD
SIMEPREVIR—Headache—Methotrexate—hematologic cancer	4.54e-05	0.00031	CcSEcCtD
SIMEPREVIR—Asthenia—Doxorubicin—hematologic cancer	4.51e-05	0.000307	CcSEcCtD
SIMEPREVIR—Pruritus—Doxorubicin—hematologic cancer	4.44e-05	0.000303	CcSEcCtD
SIMEPREVIR—Nausea—Methotrexate—hematologic cancer	4.31e-05	0.000294	CcSEcCtD
SIMEPREVIR—Rash—Epirubicin—hematologic cancer	4.28e-05	0.000292	CcSEcCtD
SIMEPREVIR—Dermatitis—Epirubicin—hematologic cancer	4.28e-05	0.000292	CcSEcCtD
SIMEPREVIR—Headache—Epirubicin—hematologic cancer	4.25e-05	0.00029	CcSEcCtD
SIMEPREVIR—Nausea—Epirubicin—hematologic cancer	4.03e-05	0.000275	CcSEcCtD
SIMEPREVIR—Rash—Doxorubicin—hematologic cancer	3.96e-05	0.00027	CcSEcCtD
SIMEPREVIR—Dermatitis—Doxorubicin—hematologic cancer	3.96e-05	0.00027	CcSEcCtD
SIMEPREVIR—Headache—Doxorubicin—hematologic cancer	3.93e-05	0.000268	CcSEcCtD
SIMEPREVIR—Nausea—Doxorubicin—hematologic cancer	3.73e-05	0.000254	CcSEcCtD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	9.68e-06	0.000127	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—IDH2—hematologic cancer	9.65e-06	0.000126	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—HMMR—hematologic cancer	9.65e-06	0.000126	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—CDK2—hematologic cancer	9.53e-06	0.000125	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—IDH1—hematologic cancer	9.48e-06	0.000124	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—TXN—hematologic cancer	9.37e-06	0.000123	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GSTO1—hematologic cancer	9.37e-06	0.000123	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—ABCC3—hematologic cancer	9.37e-06	0.000123	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—MTAP—hematologic cancer	9.3e-06	0.000122	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	9.3e-06	0.000122	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—HDC—hematologic cancer	9.23e-06	0.000121	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—SPHK1—hematologic cancer	9.17e-06	0.00012	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	9.16e-06	0.00012	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—MAPK14—hematologic cancer	9.14e-06	0.00012	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ARNTL—hematologic cancer	9.08e-06	0.000119	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	9.02e-06	0.000118	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—AKT1—hematologic cancer	9.01e-06	0.000118	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	8.94e-06	0.000117	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	8.91e-06	0.000117	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	8.89e-06	0.000116	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—FN1—hematologic cancer	8.86e-06	0.000116	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ACP5—hematologic cancer	8.83e-06	0.000116	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CA9—hematologic cancer	8.83e-06	0.000116	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—GSTP1—hematologic cancer	8.81e-06	0.000115	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—UGT1A1—hematologic cancer	8.81e-06	0.000115	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—NCOR2—hematologic cancer	8.72e-06	0.000114	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—SLC22A1—hematologic cancer	8.57e-06	0.000112	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CRABP1—hematologic cancer	8.57e-06	0.000112	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	8.53e-06	0.000112	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—PIK3CG—hematologic cancer	8.47e-06	0.000111	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CDA—hematologic cancer	8.44e-06	0.00011	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—ALOX5—hematologic cancer	8.35e-06	0.000109	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—ABCB1—hematologic cancer	8.34e-06	0.000109	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—PTPN11—hematologic cancer	8.33e-06	0.000109	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—IDH1—hematologic cancer	8.3e-06	0.000109	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	8.3e-06	0.000109	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—FHL2—hematologic cancer	8.29e-06	0.000108	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	8.23e-06	0.000108	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GSTO1—hematologic cancer	8.21e-06	0.000107	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ABCC3—hematologic cancer	8.21e-06	0.000107	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—TXN—hematologic cancer	8.21e-06	0.000107	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—AGRN—hematologic cancer	8.13e-06	0.000106	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PC—hematologic cancer	8.13e-06	0.000106	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—GSTM1—hematologic cancer	8.1e-06	0.000106	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—NCOR1—hematologic cancer	8.1e-06	0.000106	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—NUP98—hematologic cancer	8.09e-06	0.000106	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—SPHK1—hematologic cancer	8.03e-06	0.000105	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—CREBBP—hematologic cancer	7.86e-06	0.000103	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—ADCY7—hematologic cancer	7.85e-06	0.000103	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—NCOA3—hematologic cancer	7.85e-06	0.000103	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GBA—hematologic cancer	7.85e-06	0.000103	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—SLC35B2—hematologic cancer	7.85e-06	0.000103	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—NUP214—hematologic cancer	7.8e-06	0.000102	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—UGT1A1—hematologic cancer	7.72e-06	0.000101	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.72e-06	0.000101	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—IDH2—hematologic cancer	7.71e-06	0.000101	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—HMMR—hematologic cancer	7.71e-06	0.000101	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	7.68e-06	0.0001	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—MTR—hematologic cancer	7.64e-06	9.99e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—ABCG2—hematologic cancer	7.64e-06	9.99e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	7.56e-06	9.9e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—SLC22A1—hematologic cancer	7.51e-06	9.83e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CRABP1—hematologic cancer	7.51e-06	9.83e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—ENO2—hematologic cancer	7.49e-06	9.8e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—PIK3CD—hematologic cancer	7.45e-06	9.75e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ALOX5—hematologic cancer	7.32e-06	9.57e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	7.32e-06	9.57e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	7.27e-06	9.51e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GSTT1—hematologic cancer	7.26e-06	9.51e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ARNTL—hematologic cancer	7.25e-06	9.48e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—MTAP—hematologic cancer	7.18e-06	9.39e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—MTHFR—hematologic cancer	7.16e-06	9.37e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.15e-06	9.36e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—SDC1—hematologic cancer	7.1e-06	9.29e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—NUP98—hematologic cancer	7.09e-06	9.27e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CA9—hematologic cancer	7.05e-06	9.22e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ACP5—hematologic cancer	7.05e-06	9.22e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—PIK3R1—hematologic cancer	7.04e-06	9.21e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NCOR2—hematologic cancer	6.96e-06	9.1e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ADCY7—hematologic cancer	6.88e-06	9e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—NCOA3—hematologic cancer	6.88e-06	9e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—JAK2—hematologic cancer	6.84e-06	8.95e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—NUP214—hematologic cancer	6.83e-06	8.94e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	6.8e-06	8.9e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.78e-06	8.88e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—MTR—hematologic cancer	6.69e-06	8.76e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ABCG2—hematologic cancer	6.69e-06	8.76e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—IDH1—hematologic cancer	6.63e-06	8.67e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ENO2—hematologic cancer	6.56e-06	8.59e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—TXN—hematologic cancer	6.55e-06	8.58e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ABCC3—hematologic cancer	6.55e-06	8.58e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTO1—hematologic cancer	6.55e-06	8.58e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—PIK3CB—hematologic cancer	6.49e-06	8.5e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—SPHK1—hematologic cancer	6.41e-06	8.39e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.4e-06	8.38e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—FHL2—hematologic cancer	6.4e-06	8.37e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GSTT1—hematologic cancer	6.37e-06	8.33e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.31e-06	8.25e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—AGRN—hematologic cancer	6.27e-06	8.21e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	6.27e-06	8.21e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—SDC1—hematologic cancer	6.22e-06	8.14e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	6.18e-06	8.08e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—UGT1A1—hematologic cancer	6.16e-06	8.06e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CD44—hematologic cancer	6.04e-06	7.9e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—NQO1—hematologic cancer	6.04e-06	7.9e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PIK3CG—hematologic cancer	6.01e-06	7.87e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—SLC22A1—hematologic cancer	5.99e-06	7.84e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CRABP1—hematologic cancer	5.99e-06	7.84e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—IL2—hematologic cancer	5.96e-06	7.8e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.96e-06	7.8e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—HMMR—hematologic cancer	5.95e-06	7.78e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—IDH2—hematologic cancer	5.95e-06	7.78e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.91e-06	7.74e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ALOX5—hematologic cancer	5.84e-06	7.64e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CYCS—hematologic cancer	5.71e-06	7.48e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—HSP90AA1—hematologic cancer	5.68e-06	7.43e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NUP98—hematologic cancer	5.66e-06	7.4e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ARNTL—hematologic cancer	5.59e-06	7.32e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	5.58e-06	7.3e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—CREBBP—hematologic cancer	5.58e-06	7.3e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ADCY7—hematologic cancer	5.49e-06	7.19e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NCOA3—hematologic cancer	5.49e-06	7.19e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NUP214—hematologic cancer	5.45e-06	7.14e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CA9—hematologic cancer	5.44e-06	7.12e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ACP5—hematologic cancer	5.44e-06	7.12e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.4e-06	7.06e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NCOR2—hematologic cancer	5.37e-06	7.03e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—EP300—hematologic cancer	5.35e-06	7e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ABCG2—hematologic cancer	5.34e-06	6.99e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—MTR—hematologic cancer	5.34e-06	6.99e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CD44—hematologic cancer	5.29e-06	6.92e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—NQO1—hematologic cancer	5.29e-06	6.92e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	5.29e-06	6.92e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ENO2—hematologic cancer	5.24e-06	6.86e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—ALB—hematologic cancer	5.22e-06	6.83e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—SRC—hematologic cancer	5.2e-06	6.81e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—IDH1—hematologic cancer	5.12e-06	6.69e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.11e-06	6.69e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTT1—hematologic cancer	5.08e-06	6.65e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—VEGFA—hematologic cancer	5.07e-06	6.63e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—TXN—hematologic cancer	5.06e-06	6.62e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTO1—hematologic cancer	5.06e-06	6.62e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ABCC3—hematologic cancer	5.06e-06	6.62e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GSTP1—hematologic cancer	5.04e-06	6.59e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—NRAS—hematologic cancer	5.01e-06	6.55e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CYCS—hematologic cancer	5.01e-06	6.55e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5e-06	6.55e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	4.99e-06	6.53e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—HSP90AA1—hematologic cancer	4.97e-06	6.51e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—SDC1—hematologic cancer	4.97e-06	6.5e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.95e-06	6.48e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.87e-06	6.38e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—MAPK3—hematologic cancer	4.79e-06	6.27e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—ABCB1—hematologic cancer	4.77e-06	6.24e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.76e-06	6.22e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.74e-06	6.21e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.68e-06	6.13e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—TGFB1—hematologic cancer	4.65e-06	6.09e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—NCOR1—hematologic cancer	4.63e-06	6.06e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GSTM1—hematologic cancer	4.63e-06	6.06e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.63e-06	6.05e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.63e-06	6.05e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	4.61e-06	6.03e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.51e-06	5.9e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.48e-06	5.86e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GSTP1—hematologic cancer	4.41e-06	5.77e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NUP98—hematologic cancer	4.37e-06	5.71e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—KRAS—hematologic cancer	4.31e-06	5.64e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.24e-06	5.55e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.24e-06	5.55e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NQO1—hematologic cancer	4.22e-06	5.53e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CD44—hematologic cancer	4.22e-06	5.53e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NUP214—hematologic cancer	4.21e-06	5.51e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.14e-06	5.41e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.12e-06	5.4e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—MTR—hematologic cancer	4.12e-06	5.4e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—MTHFR—hematologic cancer	4.09e-06	5.35e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—NCOR1—hematologic cancer	4.05e-06	5.31e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GSTM1—hematologic cancer	4.05e-06	5.31e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ENO2—hematologic cancer	4.04e-06	5.29e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CYCS—hematologic cancer	4e-06	5.23e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PTEN—hematologic cancer	3.98e-06	5.21e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	3.97e-06	5.2e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—PIK3CA—hematologic cancer	3.96e-06	5.18e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.92e-06	5.13e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—SDC1—hematologic cancer	3.83e-06	5.02e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—TP53—hematologic cancer	3.83e-06	5.01e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—EP300—hematologic cancer	3.8e-06	4.97e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—HRAS—hematologic cancer	3.66e-06	4.79e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.6e-06	4.72e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—MTHFR—hematologic cancer	3.58e-06	4.69e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.57e-06	4.68e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTP1—hematologic cancer	3.52e-06	4.61e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PIK3CG—hematologic cancer	3.44e-06	4.5e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.41e-06	4.46e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ABCB1—hematologic cancer	3.33e-06	4.36e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CD44—hematologic cancer	3.26e-06	4.27e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NQO1—hematologic cancer	3.26e-06	4.27e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTM1—hematologic cancer	3.24e-06	4.24e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NCOR1—hematologic cancer	3.24e-06	4.24e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—AKT1—hematologic cancer	3.23e-06	4.23e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CREBBP—hematologic cancer	3.19e-06	4.17e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CYCS—hematologic cancer	3.08e-06	4.04e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.06e-06	4.01e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PIK3CD—hematologic cancer	3.02e-06	3.95e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PIK3CG—hematologic cancer	3.01e-06	3.94e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.86e-06	3.74e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PIK3R1—hematologic cancer	2.85e-06	3.73e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	2.81e-06	3.68e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CREBBP—hematologic cancer	2.79e-06	3.65e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.72e-06	3.56e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.65e-06	3.46e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PIK3CB—hematologic cancer	2.63e-06	3.45e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ALB—hematologic cancer	2.61e-06	3.42e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.57e-06	3.37e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.52e-06	3.3e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.5e-06	3.27e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.5e-06	3.27e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.5e-06	3.27e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.4e-06	3.15e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.31e-06	3.02e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—AKT1—hematologic cancer	2.29e-06	3e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PTEN—hematologic cancer	2.28e-06	2.98e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.23e-06	2.92e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.21e-06	2.89e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—EP300—hematologic cancer	2.17e-06	2.84e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PIK3CD—hematologic cancer	2.11e-06	2.76e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ALB—hematologic cancer	2.09e-06	2.73e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PIK3R1—hematologic cancer	2e-06	2.61e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PTEN—hematologic cancer	1.99e-06	2.61e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—EP300—hematologic cancer	1.9e-06	2.49e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.85e-06	2.43e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.84e-06	2.41e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.72e-06	2.25e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.63e-06	2.13e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ALB—hematologic cancer	1.61e-06	2.11e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PIK3CA—hematologic cancer	1.61e-06	2.1e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PTEN—hematologic cancer	1.59e-06	2.08e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.54e-06	2.01e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—EP300—hematologic cancer	1.52e-06	1.99e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.42e-06	1.86e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.41e-06	1.84e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—AKT1—hematologic cancer	1.31e-06	1.72e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PTEN—hematologic cancer	1.23e-06	1.61e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—EP300—hematologic cancer	1.17e-06	1.53e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—AKT1—hematologic cancer	1.15e-06	1.5e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.12e-06	1.47e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—AKT1—hematologic cancer	9.17e-07	1.2e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PIK3CA—hematologic cancer	8.66e-07	1.13e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—AKT1—hematologic cancer	7.08e-07	9.26e-06	CbGpPWpGaD
